Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in HealthEquity, Inc., Rapid7 or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how HealthEquity, Inc., Rapid7 and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About HealthEquity, Inc., Rapid7 and Inc.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Rapid7, Inc. provides cybersecurity software and services under the Rapid7, Nexpose, and Metasploit brand names. It offers Rapid7 Agent, a software-based agent that is used on assets across on-premises and cloud environments to centralize and monitor data on company’s platform; Rapid7 Network Sensor that analyzes raw end-to-end network traffic to increase visibility into user activity, pinpoint real threats, and investigations; Rapid7 Cloud Event Data Harvesting that offers visibility into changes made to cloud resources; and third-party integrations and ecosystem, as well as orchestration and automation solutions. It also offers various platforms, including Rapid7 managed threat complete consisting of managed detection response that delivers end-to-end threat detection and response; Incident Command, a security information and event management, and extended detection and response solution; Incident Response Services to prepare and respond to potential breaches; Threat Intelligence; Managed Digital Risk Protection; Exposure Command, an exposure management to provide attack surface visibility; and Command Essentials to provide strong security for workloads leveraging real-time visibility, identity analysis, and automated remediation. In addition, it provides Surface Command, a Cyber Asset Attack Service Management solution to detect and prioritize security issues from endpoint to cloud; Vector Command, a continuous red-teaming service that validates the external attack surface exposures and tests defenses; Rapid7 Cloud Security, a cloud risk and compliance management solution; Rapid7 Application Security, a dynamic application security testing tool; and Rapid7 Vulnerability Management, a vulnerability management solution that provides visibility across on-premise and remote endpoints for security. Further, it offers offloads day-to-day, advisory, and professional services. The company was incorporated in 2000 and is headquartered in Boston, Massachusetts.

Latest Health Care Providers & Services and HealthEquity, Inc., Rapid7, Inc. Stock News

As of September 4, 2026, HealthEquity, Inc. had a $7.9 billion market capitalization, compared to the Health Care Providers & Services median of $1.8 million. HealthEquity, Inc.’s stock is up 4.9% in 2026, down 0.3% in the previous five trading days and down 1.67% in the past year.

Currently, HealthEquity, Inc.’s price-earnings ratio is 34.8. HealthEquity, Inc.’s trailing 12-month revenue is $1.4 billion with a 17.4% net profit margin. Year-over-year quarterly sales growth most recently was 7.6%. Analysts expect adjusted earnings to reach $4.724 per share for the current fiscal year. HealthEquity, Inc. does not currently pay a dividend.

As of September 4, 2026, Rapid7, Inc. had a $741.4 million market cap, putting it in the 41st percentile of all stocks. Rapid7, Inc.’s stock is down 27.6% in 2026, down 17.2% in the previous five trading days and down 44.56% in the past year.

Currently, Rapid7, Inc.’s price-earnings ratio is 36.1. Rapid7, Inc.’s trailing 12-month revenue is $855.9 million with a 2.4% net profit margin. Year-over-year quarterly sales growth most recently was -1.5%. Analysts expect adjusted earnings to reach $1.799 per share for the current fiscal year. Rapid7, Inc. does not currently pay a dividend.

How We Compare HealthEquity, Inc., Rapid7 and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at HealthEquity, Inc., Rapid7 and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

HealthEquity, Inc., Rapid7 and Inc.’s Quality Grades

Company	Ticker	Quality
HealthEquity, Inc.	HQY	A
Rapid7, Inc.	RPD	C

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

HealthEquity, Inc. has a Quality Score of 97, which is Very Strong. Rapid7, Inc. has a Quality Score of 42, which is Average.

The Quality Grade Winner: HealthEquity, Inc.

As you can clearly see from the Quality Grade breakdown above, HealthEquity, Inc. has a better overall quality grade than Rapid7, Inc.. For investors who are looking for companies with higher quality than others in the same industry, HealthEquity, Inc. could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

HealthEquity, Inc., Rapid7 and Inc.’s Momentum Grades

Company	Ticker	Momentum
HealthEquity, Inc.	HQY	C
Rapid7, Inc.	RPD	C

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

HealthEquity, Inc. has a Momentum Score of 48, which is Average. Rapid7, Inc. has a Momentum Score of 57, which is Average.

The Momentum Stock Winner: No Clear Winner

Neither HealthEquity, Inc., Rapid7 or Inc. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if HealthEquity, Inc., Rapid7 or Inc. is the better investment when it comes to momentum.

HealthEquity, Inc., Rapid7 and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
HealthEquity, Inc.	HQY	B
Rapid7, Inc.	RPD	A

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

HealthEquity, Inc. has a Earnings Estimate Score of 61, which is Positive. Rapid7, Inc. has a Earnings Estimate Score of 89, which is Very Positive.

The Earnings Estimate Revisions Grade Winner: Rapid7, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Rapid7, Inc. has a better Earnings Estimate Revisions Grade than HealthEquity, Inc.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Rapid7, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other HealthEquity, Inc., Rapid7 and Inc. Grades

In addition to Quality, Momentum and Estimate Revisions, A+ Investor also provides grades for Value and Growth.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether HealthEquity, Inc., Rapid7 and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, HealthEquity, Inc., Rapid7 or Inc. Stock?

Overall, HealthEquity, Inc. stock has a Momentum Score of 48, Estimate Revisions Score of 61 and Quality Score of 97.

Rapid7, Inc. stock has a Momentum Score of 57, Estimate Revisions Score of 89 and Quality Score of 42.

Comparing HealthEquity, Inc., Rapid7 and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.